Search Results

The ACRO hCG Pregnancy Rapid Test is for use by the over the counters for the visual qualitative detection of Human Chorionic Gonadotropin (hCG) in urine. It is to be used in either dip mode or midstream mode for the early detection of pregnancy.

The ACRO HCG Pregnancy Rapid Test is designed to be tested in midstream mode and dip mode.

The ACRO HCG Pregnancy Rapid Test consists of a single test strip encased in plastic device housing, with or without an additional absorbent tip. The result is generated by immersing the tip in the urine stream for a sufficient amount of time to absorb an adequate sample volume.

It is a rapid, one-step chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin (hCG) in urine to aid in the detection of pregnancy. The test utilizes a combination of antibodies including a monoclonal hCG antibody to selectively detect elevated levels of hCG.

The ACRO HCG Pregnancy Rapid Test is a qualitative immunoassay for the detection of human chorionic gonadotropin (hCG) in urine. It is intended for over-the-counter use for early detection of pregnancy in both dip mode and midstream mode.

Here's an analysis of the provided information regarding acceptance criteria and the study that proves the device meets them:

1. Table of Acceptance Criteria and Reported Device Performance

The documents do not explicitly list formal "acceptance criteria" with numerical targets for clinical performance that would allow for a direct comparison table. However, it does state that "Lay user performance, Precision, Time Flex, Storage and Stability Studies were conducted and passed acceptance criteria". The provided comparison to the predicate device focuses more on technical specifications and design similarities.

The key performance characteristics implicitly demonstrated by the comparison to the predicate and the "passed acceptance criteria" for various studies are:

2. Sample Size Used for the Test Set and Data Provenance

The documents do not specify the exact sample sizes for the "Lay user performance, Precision, Time Flex, Storage and Stability Studies."
The data provenance (e.g., country of origin, retrospective/prospective) is also not mentioned.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

This information is not provided in the supplied text. For a qualitative diagnostic test like this, ground truth would typically be established by a reference laboratory method (e.g., quantitative hCG measurement), not by a panel of experts.

4. Adjudication Method for the Test Set

This information is not provided.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study comparing human readers with and without AI assistance was not done. This device is a standalone diagnostic test, not an AI-assisted interpretation tool for human readers.

6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) Was Done

Yes, the studies conducted (Lay user performance, Precision, Time Flex, Storage and Stability Studies) evaluate the performance of the device itself (standalone performance) as designed to be used by over-the-counter consumers. It is a rapid diagnostic test where the user visually interprets the results.

7. The Type of Ground Truth Used

While not explicitly stated for all studies, for a device detecting hCG, the ground truth would typically be established by:

• Quantitative hCG measurement: Using a laboratory-based quantitative assay to determine the actual concentration of hCG in urine samples, which then serves as the reference standard for evaluating the rapid test's sensitivity and specificity at its stated cutoff (25 mIU/ml).
• Clinical correlation/outcomes data: Confirmation of pregnancy via other clinical means for relevant samples.

8. The Sample Size for the Training Set

The concept of a "training set" is typically applicable to machine learning or AI models. This device is a lateral flow immunoassay, not an AI algorithm. Therefore, there is no "training set" in that context. The "development" or "optimization" of such a test involves various analytical studies, but not a dataset used to train an algorithm.

9. How the Ground Truth for the Training Set Was Established

As there is no "training set" in the AI sense, this question is not applicable to this device. For the analytical studies and verification/validation, ground truth (e.g., known positive/negative hCG samples derived from quantitative methods) would have been used.

Ask a specific question about this device

The ACRO hCG Pregnancy Rapid Test is used by the consumer for the visual qualitative detection of Human Chorionic Gonadotropin (hCG) in urine. It is used to detect the pregnancy of HCG in urine as an indication of pregnancy.

The ACRO HCG Pregnancy Rapid Test is designed to be tested in midstream mode. The ACRO HCG Pregnancy Rapid Test consists of a single test strip encased in plastic device housing, with or without an additional absorbent tip. The result is generated by immersing the tip in the urine stream for a sufficient amount of time to absorb an adequate sample volume. It is a rapid, one-step chromatographic immunoassay for the qualitative detection of human chorionic gonadotropin (hCG) in urine to aid in the detection of pregnancy. The test utilizes a combination of antibodies including a monoclonal hCG antibody to selectively detect elevated levels of hCG.

The ACRO HCG Pregnancy Rapid Test is a consumer-use device for the visual qualitative detection of Human Chorionic Gonadotropin (hCG) in urine to detect pregnancy.

Here's an analysis of its acceptance criteria and the supporting study:

1. Table of Acceptance Criteria and Reported Device Performance

2. Sample Size for the Test Set and Data Provenance

The provided document does not explicitly state the sample size used for the test set or the data provenance (e.g., country of origin, retrospective/prospective). It only mentions that "Lay user performance, Precision, Time Flex, Storage and Stability Studies were conducted and passed acceptance criteria."

3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications

This information is not provided in the document. The document refers to "Lay user performance" studies, which implies testing by intended users rather than experts establishing a ground truth for diagnostic accuracy. For an OTC device like a pregnancy test, the "ground truth" for lay user performance typically involves whether the user can correctly interpret the test result based on provided instructions, not necessarily the diagnostic accuracy of the device against a clinical "gold standard."

4. Adjudication Method for the Test Set

This information is not provided in the document. Given the nature of a rapid pregnancy test designed for consumer use, and the absence of specific details on expert interpretation, it's unlikely a formal adjudication method by multiple experts was employed for user performance studies.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance

This question is not applicable to the ACRO HCG Pregnancy Rapid Test. This device is a standalone in-vitro diagnostic test, not an AI-assisted diagnostic tool.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

The ACRO HCG Pregnancy Rapid Test is a standalone device in the sense that its result is determined by chemical reaction and visual interpretation by the user. There is no "algorithm only" component or AI involved. The "standalone" performance here refers to the device's inherent ability to detect hCG accurately without further human intervention beyond performing the test and reading the results. The document implies this through the "Precision, Storage and Stability Studies."

7. The Type of Ground Truth Used (Expert Consensus, Pathology, Outcomes Data, etc.)

For the performance studies (Precision, Specificity, etc.), the ground truth would likely be established through:

• Known concentrations: For precision and specificity, controlled urine samples with known hCG levels (including negative controls and samples spiked with interfering substances like hLH, hFSH, hTSH) would be used.
• WHO 4th International Standard: The document explicitly mentions "WHO 4th International Standard" for traceability, indicating that the device's performance is aligned with a recognized international standard for hCG measurement.

For the "Lay user performance" studies, the "ground truth" would likely be based on comparison with the manufacturer's expected result for the tested samples, and the user's ability to correctly obtain and interpret that result according to the instructions.

8. The Sample Size for the Training Set

This information is not applicable as the ACRO HCG Pregnancy Rapid Test is a chemical assay, not a machine learning or AI-driven device that requires a training set in that context.

9. How the Ground Truth for the Training Set Was Established

This information is not applicable for the same reason as point 8.

Ask a specific question about this device